| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 3,750 | 3,750 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| INVESTMENT - MS 8754 | 4,672 | 22,544 |
| INVESTMENT - MS 4921 | 1,453,788 | 1,472,346 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| INVESTMENT IN APPLIED STEMCELL INC | AT COST | 52,500 | 52,500 |
| INVESTMENT IN NEXBIO | AT COST | 571,170 | 571,170 |
| INVESTMENT IN DIAMEDICA THERAPEUTICS, INC. | AT COST | 182,000 | 182,000 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| INVESTMENT IN SEMANTICMD, INC. | 175,000 | 175,000 | 175,000 |
| INVESTMENT IN 7 HILLS PHARMA LLC | 0 | 68,000 | 68,000 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| BANK SERVICE CHARGE | 31 | 31 | 0 |
| Description | Amount |
|---|---|
| MISCELLANEOUS | 183 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT FEES | 16,915 | 16,915 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 350 | 350 | 0 | |
| FEDERAL TAXES | 10,346 | 0 | 0 |